About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Glaukos Corp (NY: GKOS )

122.60 -2.68 (-2.14%)
Official Closing Price Updated: 7:00 PM EDT, Jul 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 563,953
Open 124.49
Bid (Size) 49.03 (2)
Ask (Size) 140.04 (1)
Prev. Close 125.28
Today's Range 121.98 - 125.39
52wk Range 59.22 - 126.96
Shares Outstanding 50,367,507
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Analysts Have This To Say About Glaukos
Via Benzinga
This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga

Performance

YTD
+59.06%
+59.06%
1 Month
+9.48%
+9.48%
3 Month
+21.27%
+21.27%
6 Month
+32.45%
+32.45%
1 Year
+67.88%
+67.88%

More News

Read More
Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31
From Glaukos Corporation
Via Business Wire
Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
From Glaukos Corporation
Via Business Wire
Deep Dive Into Glaukos Stock: Analyst Perspectives (12 Ratings)
Via Benzinga
Analyst Ratings For Glaukos
Via Benzinga
5 Analysts Have This To Say About Glaukos
Via Benzinga
Glaukos Announces Participation in Upcoming Investor Conferences
From Glaukos Corporation
Via Business Wire
Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst
Via Benzinga
Topics Earnings
Exposures Financial
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Glaukos: Q4 Earnings Insights
Via Benzinga
Earnings Scheduled For February 21, 2024
Via Benzinga
Analyst Ratings For Glaukos
Via Benzinga
GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Glaukos Announces First Quarter 2024 Financial Results
From Glaukos Corporation
Via Business Wire
Glaukos Announces the Release of its 2023 Sustainability Report
From Glaukos Corporation
Via Business Wire
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
From Glaukos Corporation
Via Business Wire
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
From Glaukos Corporation
Via Business Wire
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
From Glaukos Corporation
Via Business Wire
Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results
From Glaukos Corporation
Via Business Wire
Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21
From Glaukos Corporation
Via Business Wire
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance
From Glaukos Corporation
Via Business Wire
Glaukos' Newly Approved Glaucoma Treatment Is The 'Biggest Driver To Watch': Analyst
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.